Duan W - Search Results

1

Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers.

Zhou G, Latchoumanin O, Hebbard L, Duan W, Liddle C, George J, Qiao L. Zhou G, et al. Among authors: duan w. Adv Drug Deliv Rev. 2018 Sep;134:107-121. doi: 10.1016/j.addr.2018.04.005. Epub 2018 Apr 6. Adv Drug Deliv Rev. 2018. PMID: 29627370 Review.

2

Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.

Shigdar S, Ward AC, De A, Yang CJ, Wei M, Duan W. Shigdar S, et al. Among authors: duan w. Br J Haematol. 2011 Oct;155(1):3-13. doi: 10.1111/j.1365-2141.2011.08807.x. Epub 2011 Aug 2. Br J Haematol. 2011. PMID: 21810089 Free article. Review.

3

Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging.

Shigdar S, Lin J, Li Y, Yang CJ, Wei M, Zhus Y, Liu H, Duan W. Shigdar S, et al. Among authors: duan w. Ther Deliv. 2012 Feb;3(2):227-44. doi: 10.4155/tde.11.148. Ther Deliv. 2012. PMID: 22834199 Review.

4

RNA aptamers targeting cancer stem cell marker CD133.

Shigdar S, Qiao L, Zhou SF, Xiang D, Wang T, Li Y, Lim LY, Kong L, Li L, Duan W. Shigdar S, et al. Among authors: duan w. Cancer Lett. 2013 Mar 1;330(1):84-95. doi: 10.1016/j.canlet.2012.11.032. Epub 2012 Nov 27. Cancer Lett. 2013. PMID: 23196060 Free article.

5

Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells.

Wilson GS, Hu Z, Duan W, Tian A, Wang XM, McLeod D, Lam V, George J, Qiao L. Wilson GS, et al. Among authors: duan w. Stem Cells Dev. 2013 Oct 1;22(19):2655-64. doi: 10.1089/scd.2012.0703. Epub 2013 Jun 8. Stem Cells Dev. 2013. PMID: 23638793 Free PMC article.

6

Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro.

Wilson GS, Tian A, Hebbard L, Duan W, George J, Li X, Qiao L. Wilson GS, et al. Among authors: duan w. Cancer Lett. 2013 Dec 1;341(2):224-30. doi: 10.1016/j.canlet.2013.08.009. Epub 2013 Aug 11. Cancer Lett. 2013. PMID: 23941832

7

Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers.

Dawar S, Singh N, Kanwar RK, Kennedy RL, Veedu RN, Zhou SF, Krishnakumar S, Hazra S, Sasidharan S, Duan W, Kanwar JR. Dawar S, et al. Among authors: duan w. Drug Discov Today. 2013 Dec;18(23-24):1292-300. doi: 10.1016/j.drudis.2013.09.009. Epub 2013 Sep 18. Drug Discov Today. 2013. PMID: 24055842 Review.

8

Aptamers as theranostic agents: modifications, serum stability and functionalisation.

Shigdar S, Macdonald J, O'Connor M, Wang T, Xiang D, Al Shamaileh H, Qiao L, Wei M, Zhou SF, Zhu Y, Kong L, Bhattacharya S, Li C, Duan W. Shigdar S, et al. Among authors: duan w. Sensors (Basel). 2013 Oct 10;13(10):13624-37. doi: 10.3390/s131013624. Sensors (Basel). 2013. PMID: 24152925 Free PMC article. Review.

9

Cancer stem cells: A contentious hypothesis now moving forward.

O'Connor ML, Xiang D, Shigdar S, Macdonald J, Li Y, Wang T, Pu C, Wang Z, Qiao L, Duan W. O'Connor ML, et al. Among authors: duan w. Cancer Lett. 2014 Mar 28;344(2):180-7. doi: 10.1016/j.canlet.2013.11.012. Epub 2013 Dec 11. Cancer Lett. 2014. PMID: 24333726 Review.

10

Cancer stem cells in prostate cancer chemoresistance.

Ni J, Cozzi P, Hao J, Duan W, Graham P, Kearsley J, Li Y. Ni J, et al. Among authors: duan w. Curr Cancer Drug Targets. 2014;14(3):225-40. doi: 10.2174/1568009614666140328152459. Curr Cancer Drug Targets. 2014. PMID: 24720286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,501 results

Search Page

Filters